Catherine Boulanger is an Infectious Disease physician affiliated with University of Miami. OpenAlex indexes 29 publications with 201 citations (h-index 6); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1611 NW 12th Ave
Box 016960 M851
Miami, FL 331361005
Telephone
305-585-1111Provider last certified this registry record 4 May 2023.
Clinical trials
- Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir Given With Rifampin
Sponsor: University of Miami
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Osprey Medical IncProgram year20214 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
51.9%Calcium channel blocker17.4%Nifedipine Er85%Amlodipine Besylate15%Part D<11 patientsStatin15%Atorvastatin Calcium66%Rosuvastatin Calcium34%Part D≥20 patients+ 4 more classes in this area
Anti-infectives
24.2%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor13.5%Dovato64%Tivicay36%Part D<11 patientsProtease Inhibitor6%Symtuza59%Prezcobix41%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
13.6%Biguanide (metformin)5%Metformin Hcl100%Part D<11 patientsGLP-1 receptor agonist3%Trulicity100%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Carlos Singer
University of Miami
Jay Spiegel, MD
University of Miami
Kara Cavuoto, MD
University of Miami
Sixto Arias, MD
University of Miami
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Myron Cohen, MD
University of North Carolina at Chapel Hill School of Medicine
Derrick W. Crook
John Radcliffe Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”